CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-04-01 | Ross Leonard S | Exercise or conversion | +5,000 | $1.81 | $9K | 79,452 |
| 2019-04-01 | Ross Leonard S | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2019-03-29 | Lurker Nancy President & CEO | Purchase | +28,500 | $1.76 | $50K | 240,200 |
| 2019-03-29 | Mazzo David J Director | Exercise or conversion | +20,000 | $1.77 | $35K | 158,000 |
| 2019-03-29 | Mazzo David J Director | Exercise or conversion · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-03-29 | Godshall Douglas Evan Director | Purchase | +17,000 | $1.75 | $30K | 29,500 |
| 2019-03-19 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −1,188 | $2.47 | $3K | 28,412 |
| 2019-03-19 | Ross Leonard S | Shares withheld for taxes | −1,735 | $2.47 | $4K | 74,452 |
| 2019-01-25 | GUYER DAVID R Director | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2018-12-22 | Ross Leonard S | Exercise or conversion | +62,892 | 94,709 | ||
| 2018-12-22 | Ross Leonard S | Shares withheld for taxes | −18,522 | $1.65 | $31K | 76,187 |
| 2018-12-22 | Ross Leonard S | Exercise or conversion · Restricted stock units | −62,892 | 0 | ||
| 2018-11-15 | ROGERS MICHAEL W Director | Exercise or conversion | +100,000 | $1.13 | $113K | 112,500 |
| 2018-11-15 | ROGERS MICHAEL W Director | Exercise or conversion · Employee Stock Option (right to buy) | −100,000 | 0 | ||
| 2018-10-25 | Landis John B. Director | Grant or award · Employee Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2018-10-12 | Lurker Nancy President & CEO | Grant or award | +76,667 | 211,700 | ||
| 2018-10-12 | Ross Leonard S | Grant or award | +20,000 | 34,762 | ||
| 2018-10-12 | Ross Leonard S | Shares withheld for taxes | −2,945 | $3.23 | $10K | 31,817 |
| 2018-10-12 | Paggiarino Dario A. Chief Medical Officer | Grant or award | +16,667 | 32,055 | ||
| 2018-10-12 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,455 | $3.23 | $8K | 29,600 |
Page 37 of 40 · 795 trades